Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1962 1
1964 1
1968 2
1969 2
1971 3
1973 1
1974 4
1976 1
1978 4
1979 6
1980 3
1981 6
1982 7
1983 7
1984 6
1985 13
1986 8
1987 7
1988 6
1989 7
1990 8
1991 9
1992 14
1993 13
1994 13
1995 14
1996 13
1997 15
1998 15
1999 13
2000 18
2001 21
2002 12
2003 17
2004 29
2005 42
2006 26
2007 32
2008 32
2009 27
2010 31
2011 49
2012 50
2013 69
2014 59
2015 64
2016 69
2017 68
2018 61
2019 58
2020 64
2021 82
2022 62
2023 51
2024 38

Text availability

Article attribute

Article type

Publication date

Search Results

1,170 results

Results by year

Filters applied: . Clear all
Page 1
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure.
Hughes TP, Mauro MJ, Cortes JE, Minami H, Rea D, DeAngelo DJ, Breccia M, Goh YT, Talpaz M, Hochhaus A, le Coutre P, Ottmann O, Heinrich MC, Steegmann JL, Deininger MWN, Janssen JJWM, Mahon FX, Minami Y, Yeung D, Ross DM, Tallman MS, Park JH, Druker BJ, Hynds D, Duan Y, Meille C, Hourcade-Potelleret F, Vanasse KG, Lang F, Kim DW. Hughes TP, et al. Among authors: minami h. N Engl J Med. 2019 Dec 12;381(24):2315-2326. doi: 10.1056/NEJMoa1902328. N Engl J Med. 2019. PMID: 31826340 Free PMC article. Clinical Trial.
Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results.
Mauro MJ, Hughes TP, Kim DW, Rea D, Cortes JE, Hochhaus A, Sasaki K, Breccia M, Talpaz M, Ottmann O, Minami H, Goh YT, DeAngelo DJ, Heinrich MC, Gómez-García de Soria V, le Coutre P, Mahon FX, Janssen JJWM, Deininger M, Shanmuganathan N, Geyer MB, Cacciatore S, Polydoros F, Agrawal N, Hoch M, Lang F. Mauro MJ, et al. Among authors: minami h. Leukemia. 2023 May;37(5):1048-1059. doi: 10.1038/s41375-023-01860-w. Epub 2023 Mar 22. Leukemia. 2023. PMID: 36949155 Free PMC article. Clinical Trial.
Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results.
Rai S, Kim WS, Ando K, Choi I, Izutsu K, Tsukamoto N, Yokoyama M, Tsukasaki K, Kuroda J, Ando J, Hidaka M, Koh Y, Shibayama H, Uchida T, Yang DH, Ishitsuka K, Ishizawa K, Kim JS, Lee HG, Minami H, Eom HS, Kurosawa M, Lee JH, Lee JS, Lee WS, Nagai H, Shindo T, Yoon DH, Yoshida S, Gillings M, Onogi H, Tobinai K. Rai S, et al. Among authors: minami h. Haematologica. 2023 Mar 1;108(3):811-821. doi: 10.3324/haematol.2022.280996. Haematologica. 2023. PMID: 36200417 Free PMC article.
Response to mRNA SARS-CoV-2 vaccination evaluated by B-cell receptor repertoire after tixagevimab/cilgavimab administration.
Funakoshi Y, Yakushijin K, Ohji G, Matsutani T, Hojo W, Sakai H, Matsumoto S, Watanabe M, Kitao A, Saito Y, Kawamoto S, Yamamoto K, Koyama T, Nagatani Y, Kimbara S, Imamura Y, Kiyota N, Ito M, Minami H. Funakoshi Y, et al. Among authors: minami h. Br J Haematol. 2023 Aug;202(3):504-516. doi: 10.1111/bjh.18932. Epub 2023 Jun 22. Br J Haematol. 2023. PMID: 37349876
Immunotherapy for cow's milk allergy.
Taniuchi S, Takahashi M, Soejima K, Hatano Y, Minami H. Taniuchi S, et al. Among authors: minami h. Hum Vaccin Immunother. 2017 Oct 3;13(10):2443-2451. doi: 10.1080/21645515.2017.1353845. Hum Vaccin Immunother. 2017. PMID: 28825866 Free PMC article. Review.
Gut bacterial aromatic amine production: aromatic amino acid decarboxylase and its effects on peripheral serotonin production.
Sugiyama Y, Mori Y, Nara M, Kotani Y, Nagai E, Kawada H, Kitamura M, Hirano R, Shimokawa H, Nakagawa A, Minami H, Gotoh A, Sakanaka M, Iida N, Koyanagi T, Katayama T, Okamoto S, Kurihara S. Sugiyama Y, et al. Among authors: minami h. Gut Microbes. 2022 Jan-Dec;14(1):2128605. doi: 10.1080/19490976.2022.2128605. Gut Microbes. 2022. PMID: 36217238 Free PMC article.
Clinical practice guidelines for peroral endoscopic myotomy.
Inoue H, Shiwaku H, Iwakiri K, Onimaru M, Kobayashi Y, Minami H, Sato H, Kitano S, Iwakiri R, Omura N, Murakami K, Fukami N, Fujimoto K, Tajiri H. Inoue H, et al. Among authors: minami h. Dig Endosc. 2018 Sep;30(5):563-579. doi: 10.1111/den.13239. Dig Endosc. 2018. PMID: 30022514
1,170 results